{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:44:58Z","timestamp":1761929098488},"reference-count":32,"publisher":"American Geophysical Union (AGU)","issue":"10","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1021\/js980025k","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T09:40:54Z","timestamp":1030268454000},"page":"1213-1218","source":"Crossref","is-referenced-by-count":75,"title":["Enhanced Skin Permeation of Sex Hormones with Novel Topical Spray Vehicles"],"prefix":"10.1029","volume":"87","author":[{"given":"Timothy M.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry L.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrie C.","family":"Finnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"13","reference":[{"key":"10.1021\/js980025k_bb0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1023\/A:1016060403438","article-title":"Current status and future prospects of transder\u2010mal drug delivery","volume":"13","author":"Guy","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1021\/js980025k_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/jps.2600840922","article-title":"Permeation of steroids through human skin","volume":"84","author":"Johnson","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1021\/js980025k_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0168-3659(92)90089-A","article-title":"Enhanced transdermal delivery of testosterone: a new physiological approach for androgen replacement in hypogo\u2010nadal men","volume":"19","author":"Mazer","year":"1992","journal-title":"J. Controlled Release"},{"key":"10.1021\/js980025k_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1523-1747.ep12701619","article-title":"Mechanism of percutaneous absorption V: percutaneous absorption of solvent deposited solids","volume":"62","author":"Scheuplein","year":"1974","journal-title":"J. Invest. Dermatol"},{"key":"10.1021\/js980025k_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0190-9622(90)70113-V","article-title":"Adverse dermatologic reactions to transdermal drug delivery systems","volume":"22","author":"Hogan","year":"1990","journal-title":"J. Am. Acad. Derma\u2010tol."},{"key":"10.1021\/js980025k_bb0035","unstructured":"Reed, B.L.; Morgan, T.M.; Finnin, B.C. Dermal penetration enhancers and drug delivery systems involving same. PCT Int. Appl. PCT\/AU97\/00091, 1997, 19 Feb."},{"key":"10.1021\/js980025k_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0733-8635(18)30094-9","article-title":"Sunscreen intolerance","volume":"13","author":"Funk","year":"1995","journal-title":"Dermatol. Clin."},{"key":"10.1021\/js980025k_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0160-3450(15)30396-2","article-title":"FDA proposes changes in sunscreen regulations","volume":"NS34","author":"DeSimone","year":"1994","journal-title":"Am. Pharm."},{"key":"10.1021\/js980025k_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000401276","article-title":"The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man","volume":"7","author":"Franz","year":"1978","journal-title":"Curr. Probl. Dermatol"},{"key":"10.1021\/js980025k_bb0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1023\/A:1015842916969","article-title":"Comparisons of in vitro nitroglycerin (GTN) flux across Yucatan pig, hairless mouse, and human skins","volume":"7","author":"Roberts","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1021\/js980025k_bb0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1023\/A:1015943200982","article-title":"Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin","volume":"7","author":"Itoh","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1021\/js980025k_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/1523-1747.ep12874561","article-title":"Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies","volume":"94","author":"Rigg","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1021\/js980025k_bb0070","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1523-1747.ep12259143","article-title":"In vitro human percutaneous penetration of benzyl alcohol and testosterone: epidermal-dermal retention","volume":"54","author":"Menczel","year":"1970","journal-title":"J. Invest. Dermatol"},{"key":"10.1021\/js980025k_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0041-008X(85)90311-4","article-title":"Percutaneous absorption in man: a kinetic approach","volume":"78","author":"Guy","year":"1985","journal-title":"Toxicol. Appl. Phar-macol."},{"key":"10.1021\/js980025k_bb0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jps.2600800521","article-title":"Compartment model for percutaneous drug absorption","volume":"80","author":"Kubota","year":"1991","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1021\/js980025k_bb0085","first-page":"10","article-title":"The eastern Children's Python in captivity","volume":"12","author":"Barnett","year":"1987","journal-title":"Thylacinus"},{"key":"10.1021\/js980025k_bb0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/jps.2600751115","article-title":"Methods for in vitro percutaneous absorption studies. Part 7. Use of excised human skin","volume":"75","author":"Bronaugh","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1021\/js980025k_bb0095","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jps.2600730831","article-title":"Increased skin permeability for lipophilic molecules","volume":"73","author":"Cooper","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1021\/js980025k_bb0100","first-page":"767","article-title":"published erratum appears in","volume":"81","author":"Ogiso","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1021\/js980025k_bb0105","unstructured":"Morgan, T.M.; Reed, B.L., Finnin, B.C. Unpublished results."},{"key":"10.1021\/js980025k_bb0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jps.2600750513","article-title":"Methods for in vitro percutaneous absorption studies. Part 6. Preparation of the barrier layer","volume":"75","author":"Bronaugh","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1021\/js980025k_bb0115","first-page":"355","article-title":"In vitro and in vivo study of the substantivity of p-aminobenzoic acid and two of its esters","volume":"36","author":"Morasso","year":"1985","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1021\/js980025k_bb0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(84)90144-2","article-title":"Androgenization of female partners of men on medroxy-progesterone acetate\/percutaneous testosterone contraception","volume":"1","author":"Delanoe","year":"1984","journal-title":"Lancet"},{"key":"10.1021\/js980025k_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archderm.1963.01590190026002","article-title":"Existence of reservoir in the stratum corneum","volume":"88","author":"Vickers","year":"1963","journal-title":"Arch. Dermatol"},{"key":"10.1021\/js980025k_bb0130","first-page":"169","article-title":"Influence of solubility, protein binding, and percutaneous absorption on reservoir formation in skin","volume":"39","author":"Miselnicky","year":"1988","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1021\/js980025k_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1523-1747.ep12518298","article-title":"In vivo correlation between stratum corneum reservoir function and percutaneous absorption","volume":"81","author":"Rougier","year":"1983","journal-title":"J. Invest. Dermatol."},{"key":"10.1021\/js980025k_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000211300","article-title":"Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin","volume":"7","author":"Hueber","year":"1994","journal-title":"Skin. Pharmacol."},{"key":"10.1021\/js980025k_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-5173(96)04768-0","article-title":"Evaluation of drug penetration in human skin ex vivo using branched fatty acids and propylene glycol","volume":"145","author":"Schneider","year":"1996","journal-title":"Int. J. Pharm"},{"key":"10.1021\/js980025k_bb0150","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1023\/A:1015931715829","article-title":"Dose-dependent enhancement effects of Azone on skin permeability","volume":"6","author":"Lambert","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1021\/js980025k_bb0155","first-page":"42","article-title":"Percutaneous therapy of painful arthritis","volume":"48","author":"Chlud","year":"1991","journal-title":"Ther. Umsch."},{"key":"10.1021\/js980025k_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.2042-7158.1995.tb05727.x","article-title":"Absorption of isosorbide dinitrate after administration as spray, ointment and microemulsion patch. An in-vitro study using the isolated perfused bovine udder","volume":"47","author":"Kietzmann","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1021\/js980025k_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0140-6736(90)90605-5","article-title":"Transdermal administration of estrogen\/progestogen hormone replacement therapy","volume":"335","author":"Whitehead","year":"1990","journal-title":"Lancet."}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915506588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915506588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T08:19:48Z","timestamp":1626855588000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915506588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["S0022354915506588"],"URL":"https:\/\/doi.org\/10.1021\/js980025k","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}